Literature DB >> 29112709

Re-aligning the ASCO and ESMO clinical benefit frameworks for modern cancer therapies.

J C Del Paggio1, R Sullivan2, W M Hopman3, C M Booth4.   

Abstract

Entities:  

Mesh:

Year:  2018        PMID: 29112709     DOI: 10.1093/annonc/mdx721

Source DB:  PubMed          Journal:  Ann Oncol        ISSN: 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  1 in total

1.  Value Frameworks: Adaptation of Korean Versions of Value Frameworks for Oncology.

Authors:  Green Bae; SeungJin Bae; Donghwan Lee; Juhee Han; Dong-Hoe Koo; Do Yeun Kim; Hee-Jun Kim; Sung Young Oh; Hee Yeon Lee; Jong Hwan Lee; Hye Sook Han; Hyerim Ha; Jin Hyoung Kang
Journal:  Int J Environ Res Public Health       Date:  2021-03-18       Impact factor: 3.390

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.